sunvozertinib
dizal pharmaceuticals
['sunvozertinib']
very encouraging results of sunvozertinib in egfrex20 patients (in progression after chemo and io). definitely, egfrex20ins is targetable !
#asco22 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
#liquidbiopsy~#screening~????